GTCbio`s 3rd Modern Drug Discovery and Development Summit
Released on: October 9, 2007, 9:59 am
Press Release Author: GTCbio
Industry: Pharmaceuticals
Press Release Summary: GTCbio announces its flagship event - the 3rd Modern Drug Discovery and Development Summit (M3D) on Nov. 28-30, 2007 in San Francisco - featuring four plenary keynote speeches from top level execs at Pfizer, Eli Lilly, Wyeth as well as Nobel Laureate Ferid Murad at UT Houston.
Press Release Body: MONROVIA, CA - GTCbio is announcing its premier research and networking forum - the 3rd Modern Drug Discovery and Development Summit taking place on November 28-30, 2007 in San Francisco, CA - covering novel drug discovery trends and developments all across the industry.
Today, GTCbio confirmed the participation of the four plenary keynote presenters who will open up this year's Modern Drug Discovery & Development Summit. Nobel Laureate Ferid Murad, Director at UT Houston, Neil Bodick, COO - Chorus at Eli Lilly, Mahdi Fawzi, EVP, Pre-Clinical Research at Wyeth Research and Keith James, SVP and Site Head at Pfizer La Jolla will be the first of over 150 speakers to present at this event.
The goal of the summit is to capture a landscape and in-depth analysis of emerging advancements in the biopharma industry. With 6 concurrent tracks on Biological Therapeutics, Drug Delivery Technology, Translational Medicine, Drug Design and Lead Optimization, Emerging Targets, and Pharmaco - Kinetics, Dynamics, Genomics and Genetics, as well as 6 study sessions (Preparing INDs, Signaling Pathways, Salvaging Compounds from Drug Attrition, Stem Cells, Systems Bio, Toxicology and Safety) and 3 pre-conference workshops (Biotech & Pharma Partnering, Bioanalytics Methods, Clinical Research) the summit will provide an outlook into the future of treatments and therapies from top experts in the industry.
For more information on GTCbio's 3rd Modern Drug Discovery and Development Summit, visit www.gtcbio.com.
ABOUT GTCbio
GTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002.
2022
